Rowland Charles A Jr sold Viking Therapeutics Inc ($VKTX) shares once on the open market in the last 365 days for a total of $2.1 million, with the most recent sale on October 27, 2025. His sales rank 3,357th among 11,678 individual insiders, below the average sale amount of $8.6 million across 6.4 transactions. He made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 9, 2026 | Generation Bio Co. | $GBIO | Rowland Charles A Jr | Director | D | Stock Option (right to buy) | 1920 | $0.00 | 0.0000 | 6,735,454 | 100.00% | 0.03% |
| Feb. 9, 2026 | Generation Bio Co. | $GBIO | Rowland Charles A Jr | Director | D | Stock Option (right to buy) | 2500 | $0.00 | 0.0000 | 6,735,454 | 100.00% | 0.04% |
| Feb. 9, 2026 | Generation Bio Co. | $GBIO | Rowland Charles A Jr | Director | D | Stock Option (right to buy) | 1500 | $0.00 | 0.0000 | 6,735,454 | 100.00% | 0.02% |
| Feb. 9, 2026 | Generation Bio Co. | $GBIO | Rowland Charles A Jr | Director | U | Common Stock | 53475 | $0.00 | 0.0000 | 6,735,454 | 100.00% | 0.79% |
| Feb. 9, 2026 | Generation Bio Co. | $GBIO | Rowland Charles A Jr | Director | D | Stock Option (right to buy) | 3000 | $0.00 | 0.0000 | 6,735,454 | 100.00% | 0.04% |
| Feb. 9, 2026 | Generation Bio Co. | $GBIO | Rowland Charles A Jr | Director | D | Stock Option (right to buy) | 4246 | $0.00 | 0.0000 | 6,735,454 | 100.00% | 0.06% |
| Feb. 9, 2026 | Generation Bio Co. | $GBIO | Rowland Charles A Jr | Director | D | Stock Option (right to buy) | 5200 | $0.00 | 0.0000 | 6,735,454 | 100.00% | 0.08% |
| Feb. 9, 2026 | Generation Bio Co. | $GBIO | Rowland Charles A Jr | Director | D | Stock Option (right to buy) | 6000 | $0.00 | 0.0000 | 6,735,454 | 100.00% | 0.09% |
| Jan. 2, 2026 | Viking Therapeutics, Inc. | $VKTX | Rowland Charles A Jr | Not found | A | Common Stock, par value $0.00001 per share | 3150 | $0.00 | 33,150.0000 | 113,036,344 | 10.50% | 0.00% |
| Jan. 2, 2026 | Viking Therapeutics, Inc. | $VKTX | Rowland Charles A Jr | Not found | A | Stock Option (Right to Buy) | 20400 | $0.00 | 20,400.0000 | 113,036,344 | 9999.99% | 0.02% |
| Oct. 27, 2025 | Viking Therapeutics, Inc. | $VKTX | Rowland Charles A Jr | Not found | M | Stock Option (Right to Buy) | 22000 | $0.00 | 0.0000 | 113,036,344 | 100.00% | 0.02% |
| Oct. 27, 2025 | Viking Therapeutics, Inc. | $VKTX | Rowland Charles A Jr | Not found | A | Common Stock, par value $0.00001 per share | 16000 | $4.48 | 46,000.0000 | 113,036,344 | 53.33% | 0.01% |
| Oct. 27, 2025 | Viking Therapeutics, Inc. | $VKTX | Rowland Charles A Jr | Not found | A | Common Stock, par value $0.00001 per share | 22000 | $5.80 | 68,000.0000 | 113,036,344 | 47.83% | 0.02% |
| Oct. 27, 2025 | Viking Therapeutics, Inc. | $VKTX | Rowland Charles A Jr | Not found | A | Common Stock, par value $0.00001 per share | 22000 | $4.88 | 90,000.0000 | 113,036,344 | 32.35% | 0.02% |
| Oct. 27, 2025 | Viking Therapeutics, Inc. | $VKTX | Rowland Charles A Jr | Not found | S | Common Stock, par value $0.00001 per share | 60000 | $35.57 | 30,000.0000 | 113,036,344 | 66.67% | 0.05% |
| Oct. 27, 2025 | Viking Therapeutics, Inc. | $VKTX | Rowland Charles A Jr | Not found | M | Stock Option (Right to Buy) | 16000 | $0.00 | 0.0000 | 113,036,344 | 100.00% | 0.01% |
| Oct. 27, 2025 | Viking Therapeutics, Inc. | $VKTX | Rowland Charles A Jr | Not found | M | Stock Option (Right to Buy) | 22000 | $0.00 | 0.0000 | 113,036,344 | 100.00% | 0.02% |
| June 4, 2025 | Generation Bio Co. | $GBIO | Rowland Charles A Jr | Not found | A | Stock Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 67,002,511 | 9999.99% | 0.04% |
| Jan. 2, 2025 | Viking Therapeutics, Inc. | $VKTX | Rowland Charles A Jr | Not found | A | Stock Option (Right to Buy) | 18800 | $0.00 | 18,800.0000 | 0 | 9999.99% | 0.00% |
| June 6, 2024 | Generation Bio Co. | $GBIO | Rowland Charles A Jr | Not found | A | Stock Option (right to buy) | 60000 | $0.00 | 60,000.0000 | 66,433,640 | 9999.99% | 0.09% |
| Jan. 2, 2024 | Viking Therapeutics, Inc. | $VKTX | Rowland Charles A Jr | Director | A | Stock Option (Right to Buy) | 32000 | $0.00 | 32,000.0000 | 0 | 9999.99% | 0.00% |